{
    "organizations": [],
    "uuid": "7a47c360c0f1bfe3dcf4d40f15974c7055577ae0",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-oncolytics-biotech-chief-medical-o/brief-oncolytics-biotech-chief-medical-officer-to-leave-effective-april-23-idUSASC09W66",
    "ord_in_thread": 0,
    "title": "BRIEF-Oncolytics Biotech Chief Medical Officer To Leave Effective April 23",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 17 (Reuters) - Oncolytics Biotech Inc:\n* ONCOLYTICS BIOTECH(R) ANNOUNCES MANAGEMENT CHANGE * ONCOLYTICS BIOTECH INC - ANDRES GUTIERREZ, CHIEF MEDICAL OFFICER WILL BE LEAVING EFFECTIVE APRIL 23, 2018 Source text for Eikon: Further company coverage:\n ",
    "published": "2018-04-18T04:14:00.000+03:00",
    "crawled": "2018-04-18T18:10:04.018+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "oncolytics",
        "biotech",
        "inc",
        "oncolytics",
        "biotech",
        "r",
        "announces",
        "management",
        "change",
        "oncolytics",
        "biotech",
        "inc",
        "andres",
        "gutierrez",
        "chief",
        "medical",
        "officer",
        "leaving",
        "effective",
        "april",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}